Pharma News

The FDA has approved AstraZeneca's Breztri Aerosphere, the first single-inhaler triple therapy for the maintenance treatment of asthma in the US.

Addex Therapeutics shares promising preclinical data for ADX71441, an allosteric modulator showing significant effects against IPF-related chronic cough.

Genexine presents preclinical data for SOX2-targeting bioPROTAC GX-BP1 at AACR 2026, showing up to 96% tumor growth inhibition and preventing tumor relapse.

A new AI-designed compound significantly reduces fentanyl intake and alters brain circuits in a preclinical rat model, offering hope for opioid use disorder.

Arcera Life Sciences and Fosun Pharma signed a strategic MoU to accelerate global neuroscience innovation and expand patient access to breakthrough therapies.

Europe’s CHMP recommends Sanofi’s tolebrutinib for secondary progressive multiple sclerosis, marking a significant win after previous regulatory setbacks.

Stanford researchers developed a stem cell and islet transplant strategy that successfully reverses Type 1 Diabetes in mice without immunosuppressive drugs.

UK-based Panthera Biopartners expands into mainland Europe by acquiring OEC, Hungary’s leading independent clinical research site network.

Alphabet's Isomorphic Labs is beginning human clinical trials for AI-designed oncology drugs, leveraging its AlphaFold technology and $600M in funding.

The CHMP has recommended Novartis' gene therapy Itvisma for spinal muscular atrophy in Europe, offering a new treatment option following FDA approval.

Tonix Pharmaceuticals shared updates on preclinical immuno-oncology candidates TNX-1700 and TNX-4700 at the AACR Annual Meeting 2026 in San Diego.

A University of Oklahoma study identified two new genetic pathways linked to lipid metabolites that influence the risk of heart disease and diabetes.